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Summary.-Up to 880% of a single dose of methyl[14C]methacrylate in rats is expired
as 14C02 in 10 days (65O% in 2 h), irrespective of the route of administration and of the
specific labelling of the propylene residue of the molecule. The implications of this
observation, and of the excretion of small amounts of [14C]methylmalonate, [14C]-
succinate and probably of [14C]3-hydroxyisobutyrate and 2-formylpropionate, and of
the formation of [14C] normal, physiological metabolites that may be accounted for
by anabolism both from 14C02 and from [14C]acetate emergent from the citric acid
cycle, are that the metabolic pathway concerned involves intermediary metabolism
and relates to mitochondrial function. Present findings are discussed in relation to
the imputations of a report of carcinogenic risk.
METHYL METHACRYLATE and its homo-
logous esters seem to be quite innocuous
substances. Thus, Deichmann (1941) and
Spealman et al. (1945) found that, in small
laboratory animals, these substances were
less acutely toxic than ethyl acetate with
an s.c. LD50of5000 mg/kg inrats, andthat
the most characteristic effects, caused by
prolonged exposure to methyl methacryl-
ate vapour, were degenerative changes of
theliver. Chroniclong-termtoxicitytesting
of methyl methacrylate in dogs and rats
by oral route (Borzelleca et al., 1964) failed
to reveal an increased mortality amongst
the animals, or any histological changes.
The dogs were given gelatin capsules con-
taining methyl methacrylate, in solution
in corn oil, for a period of 2 years, in
amounts equivalent to 10, 100 and 1000-
1500 parts/106 in the diet, and the rats
received concentrations of 6-7, 60-70 and
2000 parts/ 106 in their drinking water.
However, the present, widespread usage
of methyl methacrylate polymer for
acrylic sheet and moulding material, and a
report (Singh, Lawrence and Autian,
1972) that its i.p. administration to female
rats on Days 5, 10 and 15 of gestation
caused haemangiomas in some ofthe pups,
make a better understanding of the bio-
logical fate of this monomer in mammals
desirable.
MATERIALS AND METHODS
Chemicals.-Methacrylic acid and succinic
acid reference compounds were obtained
from Koch-light Laboratories Limited, and
were of Analar grade.
All reagents and solvents were of Analar
grade or ofthe next highest quality available.
Methylmalonic acid, m.p. 135°C, was pre-
pared by alkylation of diethyl malonate.
Formyl-2-propionic acid (methylmalonic semi-
aldehyde) was prepared by the method of
Kupiecki and Coon (1960) and the corre-
sponding alcohol, fl-hydroxyisobutyric acid,
was derived by KBH4 reduction.
Methyl[1,3 - 14C]propylene - 2 - carboxylate
with sp. act. 0-398 mCi/mmol, and with a
chemical and radiochemical purity exceeding
98%, was synthesized from [1,3-14C]acetone
via the cyanohydrin, and methyl[2-14C]-
propylene-2. carboxylate with sp. act. 0 355
mCi/mmol, and with a chemical and radio-
chemical purity exceeding 98%, was syn-
thesized similarly from [2-14C]acetone, by our
colleague Mr D. Greenslade of Imperial
Chemical Industries Limited, Petrochemicals
Division, Billingham, Cleveland. On account
of the risk of polymerization, both radio-
active chemicals were supplied in spectro-FATE OF METHYL METHACRYLATE IN RATS
scopic-grade ethanol solution, stabilized with
< 50 parts/106 of hydroquinone. These
solutions were stored at - 20°C.
Experiments in animals.-Adult male rats
(about 2 months old, 200 g body wt) were
used (Alderley Park strain (Wistar-derived),
specific-pathogen-free), and kept on a stan-
dard pellet diet.
(a) For the purpose of establishing the
excretion-retention pattern of 14C over a
10-day period, 3 rats were each administered
intragastrically a 5.7-mg/kg body weight dose
containing 4 tuCi of methyl [1,3-14C]propyl-
ene-2-carboxylate in corn-oil solution. The
animals were kept singly in glass metabolism
cages (Jencons of Hemel Hempstead, Herts.).
Unrestricted food and water were supplied,
and the urine and faeces were collected separ-
ately in the dark, and frozen at - 20°C. The
exhaled air was drawn through a gas train,
comprising successively two Dreschel bottles,
each of which contained 75 ml of ethanol at
- 70°C to remove unchanged methyl[14C]-
methacrylate, and two CO2 absorber Nilox
columns (Jencons of Hemel Hempstead)
each containing 500 ml of 2N NaOH. Pro-
ducts of excretion were collected for 10 days.
(b) Another 3 rats were each injected in a
femoral vein with a 5-7 mg/kg body weight
dose containing 4 ,uCi of methyl[1,3-14C]_
propylene-2-carboxylate in ethanol solution
(50 rz), and the excretion-retention pattern of
14C was investigated over a similar period.
(c) Three animals were each injected in a
femoral vein with a 6-8-mg/kg body weight
dose containing 4 jtCi of methyl[2-14C]-
propylene-2-carboxylate in ethanol solution
(50 plI), and the excretion-retention pattern of
14C was studied over a 10-day period.
(d) Two rats were each given a single intra-
gastric dose of methyl [2-14C]propylene-2-
carboxylate (120 mg/kg; 84 ,uCi) as a corn-oil
solution, and the excretion-retention pattern
of 14C was again studied over a 10-day period.
More than 90% ofthe urinary 14C was excret-
ed during 48 h, and this urine was used for
[14C]metabolite identification.
Measurement of radioactivity.-An auto-
mated and computerized Intertechnique
Model SL30 Liquid Scintillation Spectrometer
was used for measurement of 14C, making use
of standard channels-ratio quench-correction
curves. Liquid samples were admixed with
standard scintillator and radio-assayed direct,
and samples of faeces were burnt in an Inter-
technique "Oxymat", solid-sample oxidizer.
Characterization of unchanged methyl meth-
acrylate in the expired air.-Ethanol from the
cold traps was slowly evaporated under
N2 < 15TC, and samples of the concenitrate
were examined with a Pye model 104 gas
chromatograph that was equipped with flame-
ionization detection and coupled to an E.S.I.
Nuclear 504 Radiogas detector. The column
effluent was split in the ratio of 9: 1 between
the Radiogas detector and the flame-ioniza-
tion detector. This gas chromatograph was
fitted with glass columns (1.5 m long x 4 mm
internal diameter), which were packed with
10% (w/w) ofsqualene on Chromosorb P (80-
100 mesh size) and which were run at 75TC.
All the columns were operated at a 30 ml/min
flow-rate of a (95: 5, v/v) Air-CO2 mixture.
Under these operating conditions, methyl
methacrylate has a retention time of 5-8 min.
Systematic separation of the urinary meta-
bolites into fractions of chemically similar
substances.-A 50-ml sample of the combined
urine from the 2 rats [(d) above] was evaporat-
ed to dryness under reduced pressure, at
< 35TC. A solution of the residue in 5 ml of
0-IN KOH was percolated (20 drops/min)
through a column (bed volume, 100 ml) of
Amberlite IRA410 anion-exchange resin (14-
52 mesh size, 1-40 mg-equiv/ml) in the
CH3CO2- cycle, and the column was then
washed (60 ml/h) with 250 ml of de-ionized
water. The total eluate, which contained 54%
of the urinary 14C, was retained. 500 ml of
3N acetic acid, when percolated through the
column, stripped the remaining (46%) urinary
14C from the anion-exchange resin.
Thin-layer chronatography.-A methanol
solution of the evaporate from the bulked
aqueous washings was spotted on SiO2-gel GF
thin-layer plates, which were run with butan-
l-ol: acetic acid: water (4: 1: 1, v/v). A
major [14C] spot with an RF value of0-27 was
identified by chromatography and co-
chromatography with reference material, as
[14C] urea and gave a characteristic yellow
colour with Ehrlich's reagent. (Identification
was confirmed by reverse isotope-dilution
analysis of [14C]urea nitrate in an aliquot
portion of the methanol solution of the
evaporate from the bulked aqueous wash-
ings). A minor [14C] spot with an RF value of
0-14 on the developed plate was unidentified,
but the presence of H14CO3- was established
in further aliquot portions of the acidified
urine in Conway-diffusion units.
Radioactivity in the 3N acetic acid fraction
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was not retained by percolation through a
column (bed-volume, 50 ml) of Dowex 50W-
X8 cation-exchange resin in the H+ cycle.
Accordingly, a methanol solution of the
evaporate from the bulked effluent was
spotted on SiO2-gel GF thin-layer plates,
which were run with the same solvent system.
Chromatographic characteristics ofthe result-
ing [14C] acidic metabolites of methyl [14C]_
methacrylate are exemplified in Table II.
Radioactivity corresponding to each meta-
bolite was measured in the eluate from the
separate spots.
Gas chromatography.-Gas chromatography
of the methyl esters of the foregoing [14C]
acidic metabolites was undertaken on the
previously described gas chromatograph that
was equipped with flame-ionization detection
and coupled to an E.S.I. Nuclear 504 Radio-
gas detector. In this case, the gas chromato-
graph was fitted with glass columns (2 m
long x 4 mm internal diameter), which were
packed with 6% (w/w) of OV-101 on Supel-
coport (80-100 mesh size) and which were run
at 100°C. All the columns were operated at a
30 ml/min flow rate ofa (95 : 5, v/v) Air-CO2
mixture. Retention times of the principal
methyl esters are shown in Table II.
Analysis of triglyceride fat and cholesterol
esters.-A sample oflipid was saponified with
alcoholic KOH (1 ml of 33% aq. KOH +
9 ml of ethanol/g of lipid), under N2 in the
dark in a sealed vessel, on a water-bath at
550C for 30 min, when the cooled solution was
extracted with ether to remove cholesterol
and glycerol. The soaps were converted into
free fatty acids by acidification, and the acid
solution was re-extracted with n-hexane. The
two solvent extracts were evaporated under
reduced pressure, and the residues were dis-
solved in small volumes ofn-hexane. Extracts
were spotted separately on SiO2-gel GF thin-
layer plates, which were run either with n-
hexane diethyl ether: glacial acetic acid
(90: 20 1, v/v) or with chloroform:
acetone: 5N NH3 (10 : 80: 10, v/v).
RESULTS AND DISCUSSION
A high proportion of a dose of methyl
methacrylate is fully oxidized in rats, and
in an early investigation (Deichmann,
1941) no urinary metabolites were found.
Thus, 84-88% of a single dose (5.7 mg kg)
ofmethyl[1,3-14C]propylene-2-carboxylate
was expired from the lungs as 14C002 in
10 days, whether by parenteral or enteral
administration (Table I), and up to 65%
as 14C02 in 2 h. About half the remainder
of the dose was excreted in the urine and
the rest was retained bythebodytissues at
240 h. Pulmonary excretion of unchanged
methyl methacrylate accounted for less
than 1.0% of the dose. The same pattern
of excretion was observed when animals
were dosed anotherlabelledform ofmethyl
methacrylate, viz. methyl[2-14C]propyl-
ene-2-carboxylate (Table I). Within the
limitations of the experiment, the rate of
the initial phase ofpulmonary excretion of
14CO2 after an i.v. injection ofmethyl[l,3-
TABLE I.-Excretion and Retention ofRadioactivity in Rats after Administration of
Methyl[14C]methacrylate
Recovery of 14C (%1/O of dose)*
Form of 14C label
Methyl[1,3-14C]_
propylene-2-
carboxylate
Methyl[2-14C]-
propylene-2-
carboxylate
Exhaled gases
Unchanged
Route of Dose methyl[14C]
administration (mg/kg) Urine Faeces 14CO methacrylate
By stomach 5*7 4.7 2 -7 88-0 0*1
tubea
i.v.a 5.7 6-6 1-7 84-0 0-7
i.v.a 6-8
By stomach 120 -0
tube
7-2 1-8 84-1
6-0 3-0 76-4
Carcass
plus
skin Total
4-1 99-6
6-6 99-6
1-0 6-6 100-7
1-4 b -
* 10 days after administration.
a The data displayed are representative of that obtained in several animals.
b Unmeasured.
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of pulmonary excretion of 14CO2 in repre-
sentative rats that had been dosed dif-
ferent radioactively labellI,d forms ofmethyl
methacrylate. Each animal was given a
single injection of either-methyl[1,3-
-4C]propylene-2-carboxylate (5-7 mg/kg) 0
or methyl[2-'4C]propylene-2-carboxylate
(6-8 mg/kg) O in a femoral vein at zero time
(for details, see Methods section).
14C]propylene-2-carboxylate did not differ
significantly from that after i.v. injection
of methyl[2-14C]propylene-2-carboxylate
(Fig. 1) and half the dose is expired as
14CO2 in 90 min. It is reasonable to
suppose that on the basis of this experi-
mental evidence, all three propylene C
atoms of methacrylate were being meta-
bolized in vivo by the same sequence of
biotransformations. Moreover, the pattern
ofexcretion is not altered by a much larger
intragastric dose (120 mg kg) of methyl[2-
14C]methacrylate (Table I) but in this case
the compound was metabolized more
slowly, and pulmonary excretion of un-
changed methyl methacrylate accounted
for 1.4% ofthe dose, compared with 0.I%
for the smaller dose (5.7 mg/kg).
Hence there is a strong supposition that
the biological fate of methyl[14C]meth-
acrylate in mammals implicates the path-
ways and cycles of intermediary metabol-
ism. The scheme that is suggested for
methacrylate degradation in Fig. 2 repre-
sents the preferred pathway, in which the
branched-chain methylmalonyl CoA,
which is known to be formed in valine
catabolism, is converted by methyl-
malonyl mutase into succinyl CoA. Hence,
by that means all 4 C atoms belonging to
methacrylate would enter the citric acid
cycle simultaneouusly and be oxidized into
C02, but some anabolism of acetate into
normal, physiological metabolites might
be expected.
The fact that in vivo the ready esterifica-
tion of methacrylate by CoA directs the
entry of oxygen to the carbon atom,
which is in :-position to the carboxyl
function, makes less likely the possibility
of oz-hydroxylation, which applies to the
case ofacrylonitrile, andofa,P-dihydroxyl-
ation, which has been proposed (Pan-
tucek, 1969) for methacrylate degradation.
Whilst an o4,P-dihydroxy compound is
formed in the biosynthesis of valine from
pyruvate, the next reaction step in this
case is dehydration, and not the C-
deformylation suggested in Pantfucek's
(1969) scheme for methacrylate. In fact,
Pantiuc'ek's (1969) arsenite-inhibited in
vitro preparation may be somewhat un-
realistic, and addition of small amounts of
fumarate and malate to that preparation
does not stimulate the citric acid cycle in
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FIG. 2.-Scheme for the degradation of methacrylate in mammals.
the Krebs sense. Had the scheme leading
to pyruvate production applied to [14C]-
methacrylate degradation in rats, then
small amounts of [14C]lactic acid might
have been expected to have been excreted
in the urine, but this was not the case.
The rest of the evidence is consistent
with the scheme (Fig. 2) for the degrada-
tion of methacrylate in vivo. Thus, after
administration ofmethyl[2-14C]propylene-
2-carboxylate, that fraction of the urine
which comprises the [14C]acidic meta-
bolites (Table II) was found to contain, in
addition to [14C]methacrylic acid (0.8% of
the dose), 1.4% of [14C]methylmalonic
acid ([14C]isosuccinic acid), which arises by
hydrolysis of methylmalonyl CoA (Fig. 2),
0 2% of [14C]succinic acid from the hydro-
lysis of succinyl CoA (Fig. 2), and two
other minor constituents, which occupy
the same part ofthe chromatogram (Table
II) as P-hydroxyisobutyric acid and
formyl-2-propionic acid (methylmalonic
semialdehyde) (Fig. 2). The 14CO2 would
appear to be the source of substantial
amounts (> 2.0% ofthe dose) of[14C]urea
in the neutral fraction ofthe urine, as well
as of a small quantity of H14CO3-. At
10 days, 14C is retained in the body only by
the adipose and liver tissues, and in those
biological situations 14C is associated both
with the corresponding hydrolysis pro-
ducts and with the unsaponifiables. This
evidence suggests that, in such an experi-
TABLE II.-Thin-layer Chromatographic Properties ofMajor Urinary Acidic Metabolites
ofMethacrylate, the Gas-chromatographic Characteristics oftheir Methyl Esters, and their
Relative Proportions
Acidic metabolites
Methacrylic acid
Unidentified acid
f-Hydroxyisobutyric acid
Methylmalonic acid (isosuccinic
acid)
Methylmalonic semialdehyde
Succinic acid
RF values on SiO2-gel GO-retention times of Relative
plates developed with methyl esters (mm) proportions of
butan-l-ol:acetic acid:water Column coated with [14C]metabolites
(4: 1: 1, v/v) OV-101 and run at 1000C (% of dose)
*0-10 2-0 0-8
0-21 0-4
0 39 0-2
0-43 5-1 1-4
0 50
0-53 7-4
0-1
0-2
* Characteristically shaped, diffuse spot.
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ment, some of the [14C]acetate generated
has been elaborated into triglyceride fat
and cholesterol esters, and in fact materials
consistent with [14C] free fatty acids have
been detected in alkaline hydrolysates of
depot fat.
Thus, the rapid oxidation of [14C]-
methacrylate into 14CO2, which has been
encountered in the present investigation,
seems to be consistent with the suggested
scheme (Fig. 2). That the generation of
14CO2 was incomplete is due to body
compartmentalization, whereby a small
amount of pulmonary excretion of the
unchanged ester occurred, four ['4C]meta-
bolic intermediates were excreted in the
urine, and normal, physiological meta-
bolites were anabolized both from 14CO2
and from [14C]acetate emerging from the
citric acid cycle. On the assumption that
the metabolic route (Fig. 2) does in fact
apply in the way which has been described,
it follows that exogenous methacrylate
from the large amounts of administered
methyl methacrylate is metabolized by the
body in exactly the same way as the small
amounts of endogenous methacrylate that
are formed in the course of valine catabol-
ism. This pathway is concerned with inter-
mediary metabolism and relates to mito-
chondrial function.
Hence present evidence implies, but
does not prove, that it is rather unlikely
that methyl methacrylate metabolism
would yield damaging reactive meta-
bolites, since an acceptable pathway has
been proposed which is independent ofthe
microsomal and cytoplasmic enzymes that
are usually concerned with foreign com-
pound metabolism. The report of Singh
et al. (1972) is accordingly difficult to
reconcile and, in practice, i.p. injection
would niever be selected as the route for the
testing of embryonal-foetal toxicity and
teratogenicity per se (Hathway, 1975),
since a compound under examination
might be absorbed from the peritoneum
into the foetuses direct, and not via the
placenta.
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